SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Natsume Sōseki (HR-ET023)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 19judgment calls in the dossier
- 1protocol deviations
- 0orders and referrals without results in the record
- 4evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check outpatient management with a Glasgow-Blatchford score of 4 and no active bleeding, the choice of vonoprazan-amoxicillin dual therapy for a clarithromycin-resistant strain, the timing of the urea breath test, the decision to defer colonoscopy, and yearly endoscopic surveillance. |
| provenance review | not_started | | | The National Diet Library portrait biography, the Shinjuku City biography, the Sōseki museum biography, and two Tohoku University Soseki Collection catalogue records logged. The Kumamoto memorial pages and Takahashi's 1991 article on his stomach illness were not read. |
| safe messaging review | not_started | | | Claims about his nervous distress are marked sensitive and graded D for the documented distress and R for the period labels. No modern psychiatric diagnosis is made. His death is recorded in one sentence. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. He died in 1916, so the rule does not apply. Claims are limited to what the fetched sources state. Claims about his nervous distress are marked sensitive.
- Name (judgment call). Japanese order puts the family name first: Natsume is the family name, Sōseki a pen name (gō), and Kinnosuke his given name. The record uses the name he is known by, with identity.name_parts given “Sōseki”, family “Natsume” and family_first true, as other family-name-first records do; the notes call him Mr. Natsume. The macron in Sōseki is kept throughout. The alias “Natsume Kinnosuke” appears in no other record.
- Birth date and calendar. Japan used a lunisolar calendar until 1873. The National Diet Library gives his birth as Keiō 3, 1st month, 5th day, equal to February 9, 1867 (Gregorian), which Shinjuku City also gives; the record uses the Gregorian date and notes the original. His death in 1916 is in the Gregorian calendar.
- The London illness (judgment call). The documented fact is severe nervous distress in Britain that continued after his return (CLM-0005, D, probable). The labels used for it, shinkei suijaku (nervous breakdown, neurasthenia) and “nervous depression”, are recorded separately as R (CLM-0006), because they are period terms or translations, not diagnoses. No modern psychiatric diagnosis is made; the modern episode screens for stress and depression (PHQ-9 7 and GAD-7 8 at intake, 3 and 4 at the end) and records the history as past. A 2023 Brain and Nerve abstract mentioning an attempted overdose of sleeping pills was found while searching; it is a single uncorroborated statement on a sensitive matter, outside the brief, and was left out. No safety assessment is required (no F-code problem, PHQ-9 below 10, item 9 scored 0).
- The ulcer and Helicobacter pylori. His gastric ulcer is documented (CLM-0008, D), so the modern diagnosis (K25.4) is linked to it with placement both_with_link. Helicobacter pylori was not known in his lifetime; its role in his illness is unknown, and the modern infection, its resistance and its treatment are synthetic. Diabetes in his later years (CLM-0011) is history only; the prediabetes found at the modern preventive visit is a synthetic finding and is not linked to that claim.
- Presenting problem. The epigastric pain with black stools and anemia at intake is its own problem (R10.13), resolved at the endoscopy three days later, when K25.4 and B96.81 are recorded. The intake documents show only what was known then. Iron-deficiency anemia is diagnosed at intake from the blood tests.
- Index age and dates. The index visit on May 18, 2026 maps to May 18, 1910, when he was 43 and had had stomach illness since about May 1910, before the Nagayo hospital stay. The synthetic date of birth is February 9, 1983 (shift 116 years). The visits on May 21, June 4, June 11 and June 16, 2026 map to dates before his admission on June 18, 1910, and the last visit, August 3, 2026, maps to August 3, 1910, between his discharge on July 31 and his departure for Shuzenji on August 6; no visit falls during the hospital stay or the Shuzenji period. The modern visits are a teaching episode, not a claim about where he was.
- Regimen choice (judgment call). Clarithromycin resistance is common in Japan, so the eradication regimen follows the patient’s own biopsy PCR result. With a resistance mutation, the record uses vonoprazan 20 mg twice daily with amoxicillin 1 g three times daily for 14 days, an ACG 2024 regimen and an option in Japanese practice. Bismuth quadruple therapy, preferred by Maastricht VI and ACG when susceptibility is unknown, is described as not available for this use in Japan; this rests on general knowledge of Japanese practice rather than a fetched source and should be checked. Vonoprazan 20 mg daily for eight weeks heals the gastric ulcer (JSGE 2026), and the urea breath test is timed at least four weeks after the antibiotics and two weeks after vonoprazan.
- Outpatient care with a Glasgow-Blatchford score of 4 (judgment call). The score is calculated at intake (hemoglobin 11.2 g/dL in a man scores 3; melena scores 1; urea, pulse and blood pressure score 0). The ACG 2021 guideline supports outpatient care for scores of 0 to 1; here the melena was ten days earlier with no further bleeding, a stable hemoglobin and normal vital signs, so the record arranges endoscopy within three days with explicit instructions to call 119, rather than admission. A clinician reviewer should confirm this choice.
- Colonoscopy (judgment call). The CMID anemia monograph advises bidirectional endoscopy for iron-deficiency anemia in adult men. The record defers colonoscopy because an upper source was found and the anemia corrected after the ulcer healed; it would be done if the anemia recurred, and screening begins at 45.
- Surveillance. Moderate atrophy with focal intestinal metaplasia (OLGA stage II) leads to yearly endoscopy after eradication, the usual Japanese practice; Maastricht VI supports surveillance for advanced atrophy, at intervals of about three years in many settings.
- Setting. The brief places the modern frame in a clinic in Tokyo. The record keeps the project’s conventions (the fictional facility name, a synthetic SSN, CPT codes in plain text, USPSTF and CDC guidance) and adds Japanese guidance (JSGE 2026, JSHR 2016) and the Japanese emergency number, 119.
- Real people. His wife Kyōko, her father, his adoptive family and the guideline authors appear only in claims and sources. No modern decision, statement or health fact is attributed to them. The household is described only as married with children; no family medical history is documented in the fetched sources, so the family history is left empty.
- Synthetic content. All visits, laboratory values, vital signs, endoscopic and histology findings, the H. pylori resistance result, the urea breath test, survey scores, medicines and doses, the back strain, his height (159 cm) and weights, his ibuprofen use, diet and habits, and the health care agent are synthetic. Qualitative results (rapid urease test, histology, PCR, urea breath test, HIV and hepatitis tests) appear only in the note text.
- Sick visit. An acute low back strain during eradication therapy, chosen because it tests the most important lesson of ulcer care, avoiding NSAIDs even when they are the usual first-line treatment, and lets the record check adherence and side effects mid-course. It implies no real diagnosis.
- Preventive visit. A periodic adult preventive visit at 43 (CPT 99396 with 99497 in plain text). Judgment calls: diabetes screening at a BMI of 20.8 because Asian adults develop diabetes at lower weights, with the A1c of 5.8% to be repeated once iron is replete (iron deficiency can raise A1c); lipid screening; HIV, hepatitis B and C screening; Tdap and hepatitis B vaccination; colorectal screening from 45; gastric cancer surveillance already arranged; advance care planning limited to his own general preferences, with an unnamed agent.
- Focused visits. The three chronic-care follow-ups (three days with the endoscopy and consultation, two weeks, and eleven weeks) are documented as focused visits on the JSGE 2026 peptic ulcer guideline, the ACG 2024, Maastricht VI and JSHR H. pylori guidance, the ACG 2021 bleeding guideline, and the CMID anemia monograph. One deviation is recorded instead of an invented result: the blood count due about four weeks after starting iron was not done because no laboratory visit was booked; no harm judging by the normal hemoglobin and MCV at eleven weeks; the three-month count is booked with a reminder. Only three chronic-care follow-ups fit, because no visit may fall during the documented hospital stay or the Shuzenji period. The scar biopsy result, the three-month blood count, ferritin and A1c, and the yearly surveillance endoscopy fall after the episode ends.
- Consultation. The gastroenterology referral and the consultation by Kenji Abrahamsen-Ito, MD (a fictional consultant), on the day of the three-day visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: a clean-based gastric ulcer treated at home; margin biopsies (benign at two weeks); H. pylori positive, with the regimen chosen by PCR (dual therapy for resistance, started at two weeks); vonoprazan for eight weeks; a urea breath test and repeat endoscopy at about ten weeks (negative and healed); colonoscopy only if the anemia did not correct (it corrected); and yearly surveillance once the histology showed atrophy and intestinal metaplasia.
- Sources not used. The Kumamoto Sōseki memorial pages were not consulted, and Takahashi’s 1991 article on his stomach illness and the Shuzenji crisis (Nihon Ishigaku Zasshi, PMID 11623238) has no abstract in PubMed and was not read. The October 1910 return to Tokyo and second Nagayo admission were seen only in a search snippet and are not claimed.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-08-03 Progress note 06 (C-CDA) | Blood count on oral iron | About four weeks after starting oral iron, then every three months for a year (CMID) | Missed: the blood count due about four weeks after starting iron was not done because no laboratory visit was booked. No harm judging by today's hemoglobin of 14.0 g/dL and MCV of 85 fL. Corrective action: the three-month count is booked as a laboratory visit with a reminder |
Orders and referrals without results in the record
None.
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0006 | The city of Shinjuku calls the London illness shinkei suijaku (nervous breakdown, neurasthenia), and the Sōseki museum calls it nervous depression; both are labels of the period or translations of it, not modern diagnoses. | possible |
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0005 | D | During his stay in Britain he soon felt at odds with the study of English literature and fell into a state of severe nervous distress, which continued after his return. |
| CLM-0006 | R | The city of Shinjuku calls the London illness shinkei suijaku (nervous breakdown, neurasthenia), and the Sōseki museum calls it nervous depression; both are labels of the period or translations of it, not modern diagnoses. |
| CLM-0011 | D | In his later years he suffered, besides the gastric ulcer, from hemorrhoids and nervous distress, and developed diabetes. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-05-18 | Hemoglobin | 11.2 g/dL (low) | Low |
| 2026-05-18 | MCV | 76 fL (low) | Low |
| 2026-05-18 | RDW | 16.9% (high) | High |
| 2026-05-18 | Platelets | 418 10*3/uL (high) | High |
| 2026-05-18 | Ferritin | 8 ng/mL (low) | Low |
| 2026-05-18 | Iron | 38 ug/dL (low) | Low |
| 2026-05-18 | Total iron-binding capacity | 448 ug/dL (high) | High |
| 2026-05-18 | Transferrin saturation | 8% (low) | Low |
| 2026-05-21 | Hemoglobin | 11 g/dL (low) | Low |
| 2026-06-04 | Hemoglobin | 11.8 g/dL (low) | Low |
| 2026-06-16 | Hemoglobin A1c | 5.8% (high) | High |